Bacterial synergy in pelvic inflammatory disease

Area of Science:

• Microbiology
• Infectious Diseases
• Gynecology

Background:

• Pelvic inflammatory disease (PID) is a polymicrobial infection involving aerobic and anaerobic bacteria.
• Key pathogens include Neisseria gonorrhoeae, anaerobic cocci, Bacteroides sp., and Chlamydia trachomatis.
• N. gonorrhoeae is often found in cervical cultures but less frequently at intra-abdominal sites.

Purpose of the Study:

• To investigate the synergistic relationship between N. gonorrhoeae and anaerobic bacteria in PID.
• To highlight the impact of this synergy on disease severity and host damage.
• To recommend effective therapeutic strategies for polymicrobial PID.

Main Methods:

• Review of recent studies on PID pathogens and their interactions.
• Analysis of in-vivo synergistic relationships between N. gonorrhoeae and Bacteroides fragilis.
• Evaluation of antimicrobial agents effective against aerobic and anaerobic components of PID.

Main Results:

• N. gonorrhoeae and anaerobic bacteria, particularly Bacteroides sp., are primary causes of PID.
• A synergistic relationship exists between N. gonorrhoeae and Bacteroides fragilis, enhancing infection severity.
• This synergy promotes the emergence of encapsulated strains, increasing host damage.

Conclusions:

• PID treatment must target both aerobic and anaerobic pathogens with synergistic antimicrobial agents.
• Metronidazole, clindamycin, and cefoxitin are effective against anaerobic pathogens.
• Spiramycin and penicillins target Gram-positive aerobes and N. gonorrhoeae; aminoglycosides or third-generation cephalosporins target Gram-negative enterics.
• A combination of metronidazole and spiramycin demonstrates synergy against mixed Bacteroides sp. and N. gonorrhoeae infections.